News
There are currently no news stories available for this symbol.
RELATED RESOURCES |
Snapshot: GNOMGLOBAL X GENOMICS AND BIOTECHNOLOGY ETF13.88 as of 4:15:00pm ET 02/03/2023
Quotes delayed at least 15 min.
Log in for real time quote.
|
ETP TypeETF Net Assets
|
30-day SEC Yield AS OF 01/31/2023 | -0.28% |
---|---|
Distribution Yield (TTM) AS OF 01/31/2023 |
0.00% |
GNOM GLOBAL X GENOMICS AND BIOTECHNOLOGY ETF |
Asset Class Median | |
---|---|---|
Volume (10-Day Avg) AS OF 02/02/2023 |
90.0K | 26.5M |
1 Month Market Total Return AS OF 02/02/2023 |
+9.09 | +10.65% |
1 Year Market Total Return AS OF 12/31/2022 |
-36.27 | -23.48% |
3 Year Annualized Market Total Return AS OF 12/31/2022 |
-6.72 | +5.13% |
Beta (1 Year Month-End) AS OF 02/02/2023 |
0.94% | 1.06 |
Annual Turnover Ratio AS OF -- |
-- | 28.00% |
Net Expense Ratio AS OF 04/01/2022 |
0.50% | 0.52% |
NAV Return | Market Return | |
---|---|---|
1 Year | -36.09 | -36.27 |
3 Year | -6.63 | -6.72 |
5 Year | -- | -- |
10 Year | -- | -- |
Life | -4.86 | -5.03 |
The performance data featured represents past performance, which is no guarantee of future results. Investment return and principal value of an investment will fluctuate; therefore, you may have a gain or loss when you sell your shares. Current performance may be higher or lower than the performance data quoted.
More about Performance & RiskTXG | 10x Genomics Inc Ordinary Shares - Class A | 6.40% |
---|---|---|
1548 | Genscript Biotech Corp Class H | 4.86% |
BMRN | Biomarin Pharmaceutical Inc | 4.77% |
RARE | Ultragenyx Pharmaceutical Inc | 4.32% |
ALNY | Alnylam Pharmaceuticals Inc | 4.28% |
A | Agilent Technologies Inc | 4.20% |
QIA | Qiagen NV | 4.19% |
SRPT | Sarepta Therapeutics Inc | 4.16% |
ARWR | Arrowhead Pharmaceuticals Inc | 4.06% |
TECH | Bio-Techne Corp | 4.02% |
Commentary